The 2025 Introductory Course for Biologics Development and Manufacturing aims to provide training on the fundamentals of biologics development and manufacturing under the Global Training Hub for Biomanufacturing (GTH-B), supported by the Ministry of Health and Welfare (MoHW) of the Republic of Korea and WHO. This 2-week introductory training program covers essential topics across various fields related to biologics development and manufacturing. Designed for participants who are from countries officially classified as LMICs on the OECD DAC list and currently involved in the productions of bioproduct, this program offers a great chance to network with 150+ vaccine and biomanufacturing professionals worldwide.
The IVI Online Campus aims at strengthening the technical knowledge and expertise in manufacturing high-quality vaccines and biologics. Our online training program makes the GTH-B expertise in biomanufacturing and biologics development available anytime, anywhere, and with free access for all.
October 29, 2024, SEOUL, Republic of Korea – The International Vaccine Institute (IVI) has kicked off the 2024 Introductory Course for Standard Practice (GxP Course), aimed at enhancing the quality management
June 3, 2024, SEOUL, Republic of Korea — International Vaccine Institute (IVI) announced it will conduct the ‘2024 Introductory Course for Biologics Development and Manufacturing’ as part of the Global Training Hub
October 30, 2023, SEOUL, Republic of Korea — The International Vaccine Institute (IVI) is conducting the Introductory Course for Standard Practice (GxP Course) for a total of 180 participants, including 148 trainees from
June 19, 2023, SEOUL, Republic of Korea – The International Vaccine Institute (IVI) is conducting the 2023 Introductory Course for Biologics Development and Manufacturing for bio-R&D and production personnel from
